Netherlands-based biotechnology research company Ourobionics has recently introduced a groundbreaking biofabrication and biomanufacturing platform known as CHIMERA. This innovative system combines five different technologies into one, allowing researchers to work with various biofabrication techniques in a single place.
The development of CHIMERA was supported by a venture capital round and the NXTGEN Hightech program, positioning it as a key tool for advancing research in biomanufacturing and regenerative medicine. Maintaining high cell viability, speed, and structural precision, CHIMERA outshines traditional methods in terms of efficiency and capability.
The platform is versatile and supports a wide range of biomaterials, offering researchers flexibility in their work. Developed based on research by Prof. Suwan Jayasinghe from University College London, CHIMERA has been extensively detailed in over 150 scientific publications highlighting its ability to preserve cellular function while creating complex tissue structures.
Biofabrication research has been advancing, with new studies demonstrating novel approaches to tissue engineering. Recent developments include a 3D ice printing technique developed by researchers at Carnegie Mellon University to create blood vessel-like structures and a 3D photolithographic printing method by scientists at the University of Sydney and CMRI to create human tissues that resemble real organ structures.
Overall, CHIMERA and other innovative biofabrication techniques show promise in revolutionizing biomedical research and industrial applications by offering a streamlined and efficient approach to complex tissue engineering and biomaterial development.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
